Completion of transactions in API Business Transfer Agreement with RPG Active Pharma Limited.

August 15, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, 5th Floor, Corporate Relationship Department Plot No. C-1, G- Block, 25, P.J. Towers, Bandra - Kurla Complex, Bandra (East) Dalal Street, Mumbai – 400 051. Mumbai 400 001. Symbol: RPGLIFE Scrip Code: 532983 Dear Sir/Madam, Subject: Intimation under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’). Further to our letter dated July 29, 2026, informing you that the Company has executed a Business Transfer Agreement (‘BTA’) for transfer of its Active Pharmaceuticals Ingredients (‘API’) Business to RPG Active Pharma Limited, a wholly owned subsidiary of the Company, on a slump sale basis. We wish to inform you that in terms of the BTA, the said transaction has been completed, and transfer of API Business will be effective from August 15, 2026. The above is for your information and dissemination. Thanking you, Yours faithfully, For RPG Life Sciences Limited Rajesh Shirambekar Head – Legal & Company Secretary